Contrast Echocardiographic Perfusion Imaging in Clinical Decision-Making for Cardiac Masses in Patients With a History of Extracardiac Malignant Tumor

JACC Cardiovasc Imaging. 2019 Apr;12(4):754-756. doi: 10.1016/j.jcmg.2018.08.033. Epub 2018 Nov 15.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Clinical Decision-Making*
  • Contrast Media / administration & dosage*
  • Echocardiography*
  • Female
  • Heart Neoplasms / diagnostic imaging*
  • Heart Neoplasms / secondary
  • Heart Neoplasms / therapy
  • Humans
  • Male
  • Middle Aged
  • Myocardial Perfusion Imaging / methods*
  • Phospholipids / administration & dosage*
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Sulfur Hexafluoride / administration & dosage*

Substances

  • Contrast Media
  • Phospholipids
  • contrast agent BR1
  • Sulfur Hexafluoride